In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens
- 1 January 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (1) , 238-240
- https://doi.org/10.1128/aac.39.1.238
Abstract
Broth microdilution tests were carried out with 2,671 respiratory tract isolates from 19 medical centers throughout the continental United States. The tests compared a streptogramin (RP59500) to erythromycin, dirithromycin, clarithromycin, and azithromycin against Streptococcus pneumoniae, S. pyogenes, Haemophilus influenzae, and Moraxella catarrhalis. Against macrolide-susceptible strains, the potency of RP59500 was similar to that of the macrolides: the azalide, azithromycin, was two to four times more potent against H. influenzae. The azalide and three macrolides showed nearly complete cross-resistance. At 2.0 micrograms/ml or less, the streptogramin, RP59500, was active against both macrolide-resistant and -susceptible strains of S. pneumoniae (MIC for 50% of the strains tested, 0.25 microgram/ml; MIC for 90% of the strains tested, 0.5 microgram/ml).Keywords
This publication has 11 references indexed in Scilit:
- In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993Antimicrobial Agents and Chemotherapy, 1994
- Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- RP 59500, a new streptogramin highly active against recent isolates of North American staphylococciDiagnostic Microbiology and Infectious Disease, 1993
- Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a University Medical CenterDiagnostic Microbiology and Infectious Disease, 1993
- The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combinationJournal of Antimicrobial Chemotherapy, 1992
- Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococi with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibioticsJournal of Antimicrobial Chemotherapy, 1992
- In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1992
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988